msp 3 long synthetic peptide
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00452088)
Timeline
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- msp 3 long synthetic peptide
- msp3 long synthetic peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00652275 | Phase 2 | May 1, 2008 | African Malaria Network Trust, Malaria Research and Training Center, Bamako, Mali |
| NCT00469651 | Phase 1 | Oct 1, 2007 | African Malaria Network Trust, National Institute For Medical Research in Tanzania, National Institute for Medical Research, Tanzania, University of London |
| NCT00452088 | Phase 1 | Apr 1, 2007 | African Malaria Network Trust, University of London |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| African Malaria Network Trust | Academic/Hospital | 3 | 3 | 2 | 2007 |
| University of London | Academic/Hospital | 2 | 0 | 1 | 2007 |
| Malaria Research and Training Center, Bamako, Mali | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Institute For Medical Research in Tanzania | Government | 1 | 0 | 1 | 2007 |
| National Institute for Medical Research, Tanzania | Government | 1 | 0 | 1 | 2007 |
5 organizations
Page 1 / 1